Megan Garlapow, PhD

All articles by Megan Garlapow, PhD

• Research highlights common risks and treatments in Sjogren’s disease and PBC

  Patients with Sjogren’s syndrome face a higher risk of also developing PBC, with both diseases sharing genetic and immune features.

• Researchers uncover genetic clues driving primary biliary cholangitis risk

  Strong evidence shows that changes in certain immune system genes raise or lower the risk of developing primary biliary cholangitis.

• Global groups rally to mark International PBC Day

  For patients, these initiatives mean greater visibility for their condition, more resources to navigate care, and stronger bonds with others who understand their experience.

• Testosterone impacts immune response in autoimmune liver disease

  Women with primary biliary cholangitis (PBC) showed lower testosterone and more inflammatory T cells compared to women without the disease.

• Elevated IgG levels signal worse outcomes in primary biliary cholangitis

  Close monitoring and early intervention may help mitigate disease progression in high-IgG patients with PBC.

• High costs and frequent hospital visits burden patients with PBC

  Patients diagnosed with primary biliary cholangitis (PBC), particularly those who also develop cirrhosis, face frequent hospital visits and high medical costs, found a study published recently in the Journal of Comparative Effectiveness Research.  Analyzing two large healthcare databases from 2015 to 2023, researchers discovered that among patients who experienced at least one hospitalization or emergency […]

• Male patient diagnosed with AIH-PBC overlap syndrome

  AIH-PBC overlap syndrome is a rare autoimmune liver disease requiring early diagnosis and treatment to prevent complications.